FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * ESHELMAN FREDRIC N 2. Date of Event Requiring Statement (MM/DD/YYYY)
4/8/2020 

3. Issuer Name and Ticker or Trading Symbol Aravive, Inc. [ARAV]
(Last)       (First)       (Middle)
C/O ARAVIVE, INC. RIVER OAKS TOWER,, 3730 KIRBY DRIVE, SUITE 1200
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)
HOUSTON, TX 77098      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock  931098  I  See footnote (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Eshelman Ventures, LLC is the record holder of the securities. Dr. Fredric Eshelman is the founder and principal of Eshelman Ventures, LLC and may be deemed to beneficially own the securities held by Eshelman Ventures, LLC. Dr. Eshelman disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ESHELMAN FREDRIC N
C/O ARAVIVE, INC. RIVER OAKS TOWER,
3730 KIRBY DRIVE, SUITE 1200
HOUSTON, TX 77098
X


Eshelman Ventures, LLC
C/O ARAVIVE, INC. RIVER OAKS TOWER
3730 KIRBY DRIVE, SUITE 1200
HOUSTON, TX 77098
X



Signatures
ESHELMAN VENTURES, LLC, By: /s/ Frederic N. Eshelman, Name: Frederic N. Eshelman, Title: Managing Member 4/10/2020
**Signature of Reporting Person Date
/s/ Fredric N. Eshelman 4/10/2020
**Signature of Reporting Person Date
Aravive (NASDAQ:ARAV)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Aravive Charts.
Aravive (NASDAQ:ARAV)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Aravive Charts.